Comparative study on the efficacy of different dosage regimens of Ranibizumab in the treatment of choroid neovascularization secondary to pathological myopia

Comparative study on the efficacy of different dosage regimens of Ranibizumab in the treatment of choroid neovascularization secondary to pathological myopia

AIM: To observe the efficacy of different dosage regimens of ranibizumab in the treatment of choroid neovascularization secondary to pathological myopia(PM-CNV), and to explore the related factors affecting retreatment.METHODS: The medical records of 42 patients(43 eyes)diagnosed with PM-CNV in our...

Full description

Bibliographic Details
Main Authors: Meng-Ying Peng, Qiong Zhou
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2022-11-01
Series:Guoji Yanke Zazhi
Subjects:
pathological myopia
choroidal neovascularization
anti-vascular endothelial growth factor
ranibizumab
dosage regimen
Online Access:http://ies.ijo.cn/cn_publish/2022/11/202211017.pdf

Internet

http://ies.ijo.cn/cn_publish/2022/11/202211017.pdf

Similar Items